Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-14 Purchase |
2022-06-15 10:24 am |
Aquestive Therapeutics Inc. | AQST | Boyd Peter E. SVP-Bus. Process & Info. Tech. |
5,000 | $0.81 | $4,050 | 59,532 (Direct) |
View |
| 2022-06-08 Purchase |
2022-06-10 5:27 pm |
Aquestive Therapeutics Inc. | AQST | Barber Daniel Chief Executive Officer |
91,743 | $0.96 | $88,073 | 285,445 (Direct) |
View |
| 2022-06-08 Purchase |
2022-06-10 5:26 pm |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
45,871 | $0.96 | $44,036 | 928,742 (Direct) |
View |
| 2022-06-08 Purchase |
2022-06-10 5:26 pm |
Aquestive Therapeutics Inc. | AQST | Boyd Peter E. SVP-Bus. Process & Info. Tech. |
2,293 | $0.96 | $2,201 | 56,825 (Direct) |
View |
| 2022-06-08 Purchase |
2022-06-10 5:26 pm |
Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J General Counsel |
13,761 | $0.96 | $13,211 | 52,522 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-11-04 Option Award |
2022-11-08 10:22 am |
N/A 2032-11-04 |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-11-04 Option Award |
2022-11-08 10:21 am |
N/A 2032-11-04 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-09-06 Option Award |
2022-09-08 4:30 pm |
N/A 2032-09-06 |
Aquestive Therapeutics Inc. | AQST | Truitt Kenneth Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-08-16 Option Award |
2022-08-17 3:35 pm |
N/A 2032-08-16 |
Aquestive Therapeutics Inc. | AQST | MORRIS TIMOTHY E Director |
28,500 | $0 | 28,500 (Direct) |
View |
| 2022-08-05 Option Award |
2022-08-08 7:08 pm |
N/A 2032-08-05 |
Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:13 pm |
2023-06-22 2032-06-22 |
Aquestive Therapeutics Inc. | AQST | Cochran John Director |
25,000 | $0 | 124,486 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:02 pm |
2023-06-22 2032-06-22 |
Aquestive Therapeutics Inc. | AQST | BROWN GREGORY B Director |
25,000 | $0 | 100,085 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:22 pm |
2023-06-22 2032-06-22 |
Aquestive Therapeutics Inc. | AQST | Taglietti Marco Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:22 pm |
2023-06-22 2032-06-22 |
Aquestive Therapeutics Inc. | AQST | Krop Julie Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:21 pm |
2023-06-22 2032-06-22 |
Aquestive Therapeutics Inc. | AQST | COSTA SANTO J Director |
25,000 | $0 | 42,327 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 11:26 am |
N/A 2032-03-10 |
Aquestive Therapeutics Inc. | AQST | Barber Daniel SVP-Chief Operating Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 11:26 am |
N/A 2032-03-10 |
Aquestive Therapeutics Inc. | AQST | Wood Theresa SVP-HR and Org. Development |
70,000 | $0 | 70,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 11:26 am |
N/A 2032-03-10 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Interim CFO |
70,000 | $0 | 70,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 11:25 am |
N/A 2032-03-10 |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 11:25 am |
N/A 2032-03-10 |
Aquestive Therapeutics Inc. | AQST | Marshall Ken W. SVP, Chief Commercial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 11:25 am |
N/A 2032-03-10 |
Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J SVP, General Counsel |
160,000 | $0 | 160,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 11:24 am |
N/A 2032-03-10 |
Aquestive Therapeutics Inc. | AQST | Boyd Peter E. SVP-Bus. Process & Info. Tech. |
70,000 | $0 | 70,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 11:24 am |
N/A 2032-03-10 |
Aquestive Therapeutics Inc. | AQST | Kendall Keith J CEO and President |
375,000 | $0 | 375,000 (Direct) |
View |
| 2021-08-26 Gift |
2021-08-27 1:39 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Kendall Keith J CEO and President |
1,000 | $0 | 637,149 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-21 4:05 pm |
2022-06-15 2031-06-15 |
Aquestive Therapeutics Inc. | AQST | BROWN GREGORY B Director |
20,000 | $0 | 95,085 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 6:51 pm |
2022-06-15 2031-06-15 |
Aquestive Therapeutics Inc. | AQST | Taglietti Marco Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 6:51 pm |
2022-06-15 2031-06-15 |
Aquestive Therapeutics Inc. | AQST | Cochran John Director |
20,000 | $0 | 119,486 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 6:51 pm |
N/A 2031-06-15 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 6:51 pm |
2022-06-15 2031-06-15 |
Aquestive Therapeutics Inc. | AQST | Lurker Nancy Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 6:51 pm |
2022-06-15 2031-06-15 |
Aquestive Therapeutics Inc. | AQST | Scibetta James S Director |
20,000 | $0 | 51,635 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 6:50 pm |
2022-06-15 2031-06-15 |
Aquestive Therapeutics Inc. | AQST | Krop Julie Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 6:50 pm |
2022-06-15 2031-06-15 |
Aquestive Therapeutics Inc. | AQST | COSTA SANTO J Director |
20,000 | $0 | 37,327 (Direct) |
View |
| 2021-05-10 Gift |
2021-06-01 4:11 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Cochran John Director |
37,500 | $0 | 99,486 (Direct) |
View |
| 2021-03-09 Gift |
2021-03-16 8:20 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner |
62,500 | $0 | 7,220,655 (Direct) |
View |
| 2021-03-12 Other |
2021-03-16 8:20 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner |
5,259,492 | $0 | 7,220,655 (Indirect) |
View |
| 2021-03-12 Other |
2021-03-16 8:20 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Cochran John Director |
61,901 | $0 | 198,887 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Krop Julie Director |
28,500 | $0 | 28,500 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Interim CFO |
2,500 | $0 | 2,500 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Wood Theresa SVP-HR and Org. Development |
27,000 | $0 | 27,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Kendall Keith J CEO and President |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Marshall Ken W. SVP, Chief Commercial Officer |
40,000 | $0 | 40,000 (Direct) |
View |